Research and Clinical Trials

Artificial intelligence reduced by twofold the rate at which precancerous polyps were missed in colorectal cancer screening, reports Mayo-led research team.

Researchers used a new immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors in mouse models.

Clinical trials help physician-scientists improve cancer treatment, and can provide experimental, cutting-edge treatment options.

Researchers validated a diagnostic test for melanoma that combines genetic information from a skin biopsy with other characteristics to show whether patients are at risk of their cancer spreading.

New research finds that patients with ASXL1-mutant chronic myelomonocytic leukemia have distinctive epigenetic changes that can activate harmful genes and cause the cancer to grow faster.

Mayo Clinic researchers found disparities in data quality among racial groups in The Cancer Genome Atlas, one of the largest and most widely used cancer research datasets.

Advances in breast cancer prevention have resulted in new and innovative opportunities to modify breast cancer risk.

Researchers have learned you don't need a family history of colorectal cancer to have a genetic mutation that predisposes you to the disease.

A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from therapies.

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.